Clinical research

Open public recruiting

　ID　 Research title Target
diseases
symptom		 Status UMIN* Remarks
JORTC
-SUP04 		A single-arm exploratory study for the efficacy and safety of acupuncture in patients with taxane-induced peripheral neurotoxicity taxane-induced peripheral neurotoxicity Open
public
recruiting		 UMIN
000048478		 －
JORTC
PhaseR
(NMRD) 		PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Dyspnea in Patients with Non-malignant Respiratory Diseases Study non-malignant respiratory diseases Open
public
recruiting		 UMIN
000049267		 －
JORTC
PON02 		Ramelteon for prevention of postoperative delirium in delirium high-risk cancer patients.: A randomized, double-blind, placebo-controlled multi-center trial, JORTC-PON02/J-SUPPORT2103/NCCH2103. (RAMP trial) delirium Open
public
recruiting		 jRCTs
031210673		 －
JORTC
PAL20 		Exploratory study investigating the efficacy, safety of prophylactic olanzapine for opioid-induced nausea and vomiting in patients with cancer (JORTC-PAL20) opioid-induced nausea and vomiting Open
public
recruiting		 jRCTs
031220008		 －
JORTC
PAL18 		Effects of opioid and naldemedine combined therapy on opioid-induced constipation for cancer patients with cancer pain: Randomized placebo-controlled double-blind trial cancer Open
public
recruiting		 jRCTs
031200397		 －
ACO Investigate the benefits of telemedicine home support systems: A pilot randomized controlled trial Frailty Enrolling
by
invitation		 UMIN
000038207		 Grant-in-Aid for Scientific Research
JORTC
-PAL16 		International, multi-centre, double-blind, dose increment, parallel-arm, randomised controlled of duloxetine versus pregabalin over 14 days for opioid unresponsive cancer-related neuropathic pain Neuropathic Cancer Pain Open
public
recruiting		 jRCTs
051190097		 Japan Agency for Medical Research and Development
JORTC
-ONC10
LANDMARC 		The Comprehensive Multi Center Survey on Sexual Dysfunction following Conventional Laparoscopic and Modern Minimally Invasive Approaches for Rectal Cancer (the LANDMARC Study) Rectal Cancer Open
public
recruiting		 UMIN
000037298		 －
JORTC
-RHB02 		A study to confirm the efficacy of specialized rehabilitation for cancer patients in palliative care units; A multi-center randomized controlled trial Cancer
Rehabilitation　Medicine		 Open
public
recruiting		 UMIN
000037298		 Japan Agency for Medical Research and Development
JORTC
-PAL15 		Randomized, placebo-controlled phase II study of efficacy of morphine for dyspnea in patients with interstitial lung disease: JORTC-PAL15 Interstitial lung disease Open
public
recruiting		 jRCTs
051190030		 －
JORTC
-CAM04 		Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients undergoing Anthracycline or Taxan-based Anticancer Drug: Randomized, Double-blind, Placebo controlled Confirmatory study Breast Neoplasms Open
public
recruiting		 jRCTs
031180324		 Amino Up
Co., Ltd.
JORTC
-ONC07 		Colonic stent for "Bridge to Surgery" prospective randomized controlled trial comparing treatment with non-stenting surgery in stage II/III obstructive colon cancer. Colorectal cancer Open
public
recruiting		 UMIN
000026158		 －

Preinitiation

－－－－－－


Completion of registration

　ID　 Research title Target
diseases
symptom		 Status UMIN* Remarks
JORTC
-KMP03 		Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients with Uterine Corpus or Cervical Cancer Treated with Cisplatin-Based Regimen -Placebo-Controlled, Double-Blind, Randomized Confirmatory Study (Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting) Uterine cervical
Corpus cancer		 completion
of
registration		 jRCT
1011190007		 Japan Agency for Medical Research and Development
PhaseR PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Cancer Dyspnea Study Cancer dyspnea completion
of
registration		 UMIN
000038918		 －
JORTC
-PAL21 		A Clinical Study of the Efficacy and Safety of Corticosteroids for Cancer-induced Neuropathic Pain. Cancer pain completion
of
registration		 UMIN
000040584		 Japan Science and Technology Agency
JORTC
-PAL19 		Cross-sectional research of interaction and causal relationship among factors related to dyspnea in patients with cancer Cancer completion
of
registration		 UMIN
000038820		 －
JORTC
-SUP03 		The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors regorafenib (PMTMHFS) Colorectal cancer completion
of
registration		 jRCTs
031180096		 －
JORTC
-ONC05
(PIT-3) 		A phase II trial of induction erlotinib followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 EGFR mutated non-small cell lung cancer. Stage IIIA-N2 EGFR mutated, Non-small cell lung cancer completion
of
registration		 UMIN
000026197		 －
JORTC
-ONC03
(PIT-2) 		A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 squamous-cell non-small cell lung cancer. Stage IIIA-N2 Squamous, Non-small cell lung cancer completion
of
registration		 jRCTs
031180403		 －
JORTC
-ONC04
(CRES3T) 		A multicentre,single arm,confirmatory trial to evaluate the effectiveness of induction CDDP plus TS-1 with concurrent radiotherapy(66Gy) followed by surgical resection in patients with superior sulcus tumor Superior sulcus tumor completion
of
registration		 UMIN
000014386		 National Cancer Center Research and Development Fund

＊ jRCT(Japan Registry of Clinical Trials）臨床研究実施計画・研究概要公開システム。このシステムは、医療機関等で実施される臨床研究について、「臨床研究法」及び「再生医療等の安全性の確保等に関する法律」の規定に基づき、厚生労働大臣に対して、実施計画の提出などの届出手続を行うためのシステムです。また、同法に規定する臨床研究実施基準に基づき、世界保健機関（WHO）が公表を求める事項や研究過程の透明性確保及び国民の臨床研究への参加の選択に資する情報について公開しています。
https://jrct.niph.go.jp/

＊ UMIN CTR is a Japanese clinical trial registration system operated by UMIN (University hospital Medical Information Network). UMIN CTR is approved by ICMJE (International Committee of Medical journal Editors).
http://www.umin.ac.jp/ctr/index-j.htm



Published：2012.12.03
Last updated：2023.04.27